Carregant...
The role of basal insulin and GLP-1 receptor agonist combination products in the management of type 2 diabetes
The prevalence of type 2 diabetes necessitates the development of new treatment options to individualize therapy. Basal insulin has been a standard treatment option for years, while glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have grown in use over the past decade due to glucose-lowering e...
Guardat en:
| Publicat a: | Ther Adv Endocrinol Metab |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5958427/ https://ncbi.nlm.nih.gov/pubmed/29796245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018818763698 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|